Home > Riviste > Minerva Biotecnologica > Fascicoli precedenti > Minerva Biotecnologica 1999 September;11(3) > Minerva Biotecnologica 1999 September;11(3):175-85

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

MINERVA BIOTECNOLOGICA

Rivista di Biologia Molecolare e Biotecnologie


Indexed/Abstracted in: EMBASE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,25


eTOC

 

  APPLICATIONS OF PEPTIDES NUCLEIC ACIDS (PNA) IN MOLECULAR MEDICINE AND BIOTECHNOLOGYFREEfree


Minerva Biotecnologica 1999 September;11(3):175-85

Copyright © 1999 EDIZIONI MINERVA MEDICA

lingua: Inglese

Conformational features of Peptidic Nucleic Acids for the rational design of biologically active PNAs and hybrid PNA-oligonucleotides

Saviano M., Bucci E., Romanelli A., Pedone C.

Centro di Studio di Biocristallografia del CNR and Centro Interuniversitario di Ricerca sui Peptidi Bioattivi, Dipartimento di Chimica, Napoli, Italy


FULL TEXT  


The ­search for new oli­go­nu­cleo­tides ­with ­improved prop­er­ties rep­re­sents an impor­tant ­step for the devel­op­ment of oli­go­nu­cleo­tides as pow­erful bio­mo­lec­ular ­tools, anti­sense and ­antigene ­agents, molec­ular ­probes and bio­sen­sors. One of the ­most inter­esting of the new deriv­a­tives is Pep­tide ­Nucleic ­Acid (PNA), an ana­logue of DNA in ­which the back­bone is a pseu­do­pep­tide ­rather ­than a ­sugar. PNA ­mimics the beha­viour of DNA and ­binds com­ple­men­tary ­nucleic ­acid ­strands, ­with ­higher ­affinity and spec­i­ficity ­than cor­re­sponding oli­go­nu­cleo­tides. The ­unique prop­er­ties of PNA ­open up ­novel molec­ular ­biology and bio­chem­istry appli­ca­tions ­that are unachiev­able ­with tra­di­tional oli­go­nu­cleo­tides and pep­tides. The non-­charged ­nature of the PNA back­bone is an impor­tant fea­ture ­leading to ­higher ­thermal ­stability of PNA/DNA ­duplexes com­pared to DNA/DNA ­duplexes and ­stability of PNA ­duplexes ­with DNA inde­pen­dent of ­salt con­cen­tra­tion. PNA oli­gomers are ­resistant to deg­ra­da­tion by ­enzymes, and the life­time of ­these com­pounds is ­extended ­both in ­vivo and in ­vitro. The direc­tion of ­rational ­drug ­design of new PNA ­with spe­cific func­tions ­depends crit­i­cally on under­standing the ­basic prin­ci­ples of spec­i­ficity of bio­mo­lec­ular rec­og­ni­tion for ­this ­class of mole­cules. ­Thus, the com­par­a­tive anal­ysis of con­for­ma­tional ­data on PNA/PNA, PNA/RNA, PNA/DNA ­duplexes and PNA2/DNA ­triplex rep­re­sents the ­starting ­point for the ­design of new ­PNAs. In addi­tion, the inves­ti­ga­tion of mod­i­fied ­PNAs and PNA/DNA chi­meras may pro­vide a new gen­er­a­tion of ­nucleic ­acid ­mimetics ­with ­large-­scale appli­ca­tion in bio­log­ical ­systems.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail